Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials Sponsored by H. Tolga Çelik
Total 1 results
H. Tolga Çelik
Completed
The Effect of Probiotic Supplement on Urinary D-lactic Acid Level in Newborns
Antibiotic Side Effect
Turkey
Sponsors and Collaborators
Caritas Freetown
ProteoSys AG
University Medical Center Goettingen
The Fifth Affiliated Hospital of Zunyi Medical College
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Norsk Proteinintolerance, Norway
Victor Montori
AMTC & Associates
San MediTech(Huzhou)Co.,Ltd.
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
Rui-hua Xu, MD, PhD
Fondren Orthopedic Group L.L.P.
Cardresearch
Diego Hernan Giunta, MD
Alberta Children's Hospital, Calgary, Canada
CRMBM-CEMEREM
Donders Institute for Brain, Cognition and Behavior
Celtaxsys Aus Pty Limited
Elim Pediatric Pharmaceuticals Inc.
Societa Italiana di Endoscopia Digestiva
View Full List
Medical Conditions
Tube Disorders Eustachian
Gynecologic Cancer
Disturbance of Activity and Attention
Postcomatose Unawareness State
Prostate Cancer Recurrent
Non-dystrophic Myotonias
Normal Diameter of Optic Nerve
Malignant Ascites Due to Epithelial Carcinoma
Non-compressible Torso Hemorrhage
Lymphedema of Arm
Atrial Fibrillation, Postoperative
Spermatogenesis Arrest
Fever, Sweats, and Hot Flashes
Plasmodium Falciparum Malaria (Drug Resistant)
Fibromyalgia Syndrome, Primary
Orbital Tumor
Tularaemia
Stereotactic Radioablation for Ventricular Tachycardia
Auditory Hallucination, Verbal
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
View Full List
Drug Interventions
Ruxolitinib
Oxycodone, fentanyl
Atezolizumab
Flibanserin 100 mg dose every evening
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Polyethylene glycol 3350
Cytarabine ARA-C
SERETIDE Diskus
Epimedium Prenylflavonoids Extract
Bortezomib/dexamethasone
Methotrexate
Topotecan
Cetrorelix 78 mg + 78 mg
Enzalutamide, Abiraterone
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Lamivudine
Indoximod
PF-00868554
Mupirocin Calcium
Insulin
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Croatia
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Jamaica
Contract Research Organizations in Lithuania
Contract Research Organizations in Madagascar
Contract Research Organizations in New Zealand
Contract Research Organizations in Paraguay
Contract Research Organizations in Rwanda
Contract Research Organizations in Senegal
Contract Research Organizations in Suriname
Contract Research Organizations in Sweden
Contract Research Organizations in Zambia
CRO list by country
CROs in Morocco
4Clinics
SGS
MCT
"Gaya Pharma" by Morocco Africa Health & Pharma (MAHP)
All CROs in Morocco
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe